Higher Doses of AXAL Vaccine Are Safe, Effective in Certain Types of Cervical Cancer, Says Advaxis
News
A recent trial showed the anti-cancer vaccine axalimogene filolisbac, also known as ADXS11-001 or AXAL, to be well tolerated at higher doses, with promising results against persistent or recurrent metastatic ... Read more